Inventor
WOOD KRISTY M
US18 patents
⚠️ This page may combine multiple inventors who share the name “WOOD KRISTY M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MODERNA THERAPEUTICS INC
10 patentsUS9587003B2Mar 7, 2017
Modified polynucleotides for the production of oncology-related proteins and peptides
MODERNA THERAPEUTICS INC67 citations99
US9572896B2Feb 21, 2017
In vivo production of proteins
MODERNA THERAPEUTICS INC75 citations99
US9254311B2Feb 9, 2016
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC126 citations99
US9221891B2Dec 29, 2015
In vivo production of proteins
MODERNA THERAPEUTICS INC113 citations99
US9572897B2Feb 21, 2017
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
MODERNA THERAPEUTICS INC65 citations98
US9504734B2Nov 29, 2016
Modified polynucleotides for the production of nuclear proteins
MODERNA THERAPEUTICS INC56 citations98
US9295689B2Mar 29, 2016
Formulation and delivery of PLGA microspheres
MODERNA THERAPEUTICS INC98 citations97
US9271996B2Mar 1, 2016
Formulation and delivery of PLGA microspheres
MODERNA THERAPEUTICS INC12 citations91
US9827332B2Nov 28, 2017
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC7 citations84
US9782462B2Oct 10, 2017
Modified polynucleotides for the production of proteins associated with human disease
MODERNA THERAPEUTICS INC7 citations84
MODERNATX INC
4 patentsUS10772975B2Sep 15, 2020
Modified Polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC37 citations98
US9814760B2Nov 14, 2017
Modified polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC15 citations92
US9828416B2Nov 28, 2017
Modified polynucleotides for the production of secreted proteins
MODERNATX INC3 citations84
US10258698B2Apr 16, 2019
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
MODERNATX INC12 citations79
modeRNA Therapeutics
4 patentsUS8999380B2Apr 7, 2015
Modified polynucleotides for the production of biologics and proteins associated with human disease
modeRNA Therapeutics258 citations98
US8680069B2Mar 25, 2014
Modified polynucleotides for the production of G-CSF
modeRNA Therapeutics180 citations98
US8754062B2Jun 17, 2014
DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
modeRNA Therapeutics204 citations97
US8664194B2Mar 4, 2014
Method for producing a protein of interest in a primate
modeRNA Therapeutics90 citations97